Company to Highlight the complete solution to the GLP-1 weight regain crisis: Only All-Oral Dual-Mechanism Metabolic Platform in Clinical Development, Featuring First-in-Class Oral GLP-1 Agonist and Muscle-Selective AMPK Activator
January 9, 2026
· 1 min read